VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Feb. 6, 2006) - ZECOTEK MEDICAL SYSTEMS INC. (“ZMS” or the “COMPANY”) (TSX VENTURE:ZMS) - The Company is pleased to announce the appointment of Mr. David Wynne to its Board of Directors. Mr. Wynne has over twenty-five years experience in international business development, venture capital, finance and operations. He is currently a partner at Upstream Ventures, a venture capital firm in Singapore. He was previously founder, COO and Chief Business Officer at MerLion Pharmaceuticals, a Singapore-based drug discovery company which he helped found in 2001. Previously he was Senior Vice President and a Board representative of Transpac Capital, one of Asia’s oldest and largest venture capital companies. Mr. Wynne has served on the Executive Board of the Singapore Venture Capital Association and is presently on the Executive Committee of the Singapore Biotech Association. Before entering the private sector he served as a senior diplomat for Canada in Korea, Japan and Singapore and in APEC where he served as Canada’s representative to the APEC Budget and Administration Committee and as the Canadian Deputy Chair of the Economic Committee. He was a co-founder of the Canadian software company Greenbook, which produced one of the first hypertext authoring tools for the Internet. He earned a Bachelor of Arts degree from Concordia University, Montreal, Canada and a Master of Arts in Public Administration & Economics from Carleton University, Ottawa, Canada.
